202 related articles for article (PubMed ID: 12603227)
1. Does cannabis use predict poor outcome for heroin-dependent patients on maintenance treatment? Past findings and more evidence against.
Epstein DH; Preston KL
Addiction; 2003 Mar; 98(3):269-79. PubMed ID: 12603227
[TBL] [Abstract][Full Text] [Related]
2. Cannabis use and treatment outcome in methadone maintenance.
Nixon LN
Addiction; 2003 Sep; 98(9):1321-2; author reply 1322-3. PubMed ID: 12930220
[No Abstract] [Full Text] [Related]
3. Promoting abstinence from cocaine and heroin with a methadone dose increase and a novel contingency.
Epstein DH; Schmittner J; Umbricht A; Schroeder JR; Moolchan ET; Preston KL
Drug Alcohol Depend; 2009 Apr; 101(1-2):92-100. PubMed ID: 19101098
[TBL] [Abstract][Full Text] [Related]
4. A randomized controlled trial of interim methadone maintenance.
Schwartz RP; Highfield DA; Jaffe JH; Brady JV; Butler CB; Rouse CO; Callaman JM; O'Grady KE; Battjes RJ
Arch Gen Psychiatry; 2006 Jan; 63(1):102-9. PubMed ID: 16389204
[TBL] [Abstract][Full Text] [Related]
5. Predictors of heroin abstinence in opiate substitution therapy in heroin-only users and dual users of heroin and crack.
Heidebrecht F; MacLeod MB; Dawkins L
Addict Behav; 2018 Feb; 77():210-216. PubMed ID: 29065377
[TBL] [Abstract][Full Text] [Related]
6. Methadone treatment outcomes appear mainly unaffected by cannabis use.
Seivewright N
Addiction; 2003 Mar; 98(3):251-2. PubMed ID: 12603223
[No Abstract] [Full Text] [Related]
7. Chronic cannabis use does not affect the normalization of hypothalamic-pituitary-adrenal (HPA) axis induced by methadone in heroin addicts.
Nava F; Manzato E; Lucchini A
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1089-94. PubMed ID: 17466429
[TBL] [Abstract][Full Text] [Related]
8. Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users.
Banta-Green CJ; Maynard C; Koepsell TD; Wells EA; Donovan DM
Addiction; 2009 May; 104(5):775-83. PubMed ID: 19344438
[TBL] [Abstract][Full Text] [Related]
9. Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation.
Connock M; Juarez-Garcia A; Jowett S; Frew E; Liu Z; Taylor RJ; Fry-Smith A; Day E; Lintzeris N; Roberts T; Burls A; Taylor RS
Health Technol Assess; 2007 Mar; 11(9):1-171, iii-iv. PubMed ID: 17313907
[TBL] [Abstract][Full Text] [Related]
10. Use of methadone take-home contingencies with persistent opiate and cocaine abusers.
Chutuape MA; Silverman K; Stitzer ML
J Subst Abuse Treat; 1999 Jan; 16(1):23-30. PubMed ID: 9888118
[TBL] [Abstract][Full Text] [Related]
11. Supervised daily consumption, contingent take-home incentive and non-contingent take-home in methadone maintenance.
Gerra G; Saenz E; Busse A; Maremmani I; Ciccocioppo R; Zaimovic A; Gerra ML; Amore M; Manfredini M; Donnini C; Somaini L
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):483-9. PubMed ID: 21147192
[TBL] [Abstract][Full Text] [Related]
12. Buprenorphine versus methadone for opioid dependence: predictor variables for treatment outcome.
Gerra G; Borella F; Zaimovic A; Moi G; Bussandri M; Bubici C; Bertacca S
Drug Alcohol Depend; 2004 Jul; 75(1):37-45. PubMed ID: 15225887
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of cocaine contingency management in heroin-assisted treatment: Results of a randomized controlled trial.
Blanken P; Hendriks VM; Huijsman IA; van Ree JM; van den Brink W
Drug Alcohol Depend; 2016 Jul; 164():55-63. PubMed ID: 27177805
[TBL] [Abstract][Full Text] [Related]
14. No evidence for reduction of opioid-withdrawal symptoms by cannabis smoking during a methadone dose taper.
Epstein DH; Preston KL
Am J Addict; 2015 Jun; 24(4):323-8. PubMed ID: 25846329
[TBL] [Abstract][Full Text] [Related]
15. Pre-treatment characteristics, program philosophy and level of ancillary services as predictors of methadone maintenance treatment outcome.
Saxon AJ; Wells EA; Fleming C; Jackson TR; Calsyn DA
Addiction; 1996 Aug; 91(8):1197-209. PubMed ID: 8828247
[TBL] [Abstract][Full Text] [Related]
16. Intravenous and intranasal heroin-dependent treatment-seekers: characteristics and treatment outcome.
Highfield DA; Schwartz RP; Jaffe JH; O'Grady KE
Addiction; 2007 Nov; 102(11):1816-23. PubMed ID: 17784892
[TBL] [Abstract][Full Text] [Related]
17. Multimodal drug addiction treatment: a field comparison of methadone and buprenorphine among heroin- and cocaine-dependent patients.
Vigezzi P; Guglielmino L; Marzorati P; Silenzio R; De Chiara M; Corrado F; Cocchi L; Cozzolino E
J Subst Abuse Treat; 2006 Jul; 31(1):3-7. PubMed ID: 16814005
[TBL] [Abstract][Full Text] [Related]
18. Desipramine in opioid-dependent cocaine abusers maintained on buprenorphine vs methadone.
Oliveto AH; Feingold A; Schottenfeld R; Jatlow P; Kosten TR
Arch Gen Psychiatry; 1999 Sep; 56(9):812-20. PubMed ID: 12884887
[TBL] [Abstract][Full Text] [Related]
19. Retrospective study of outcomes, for patients admitted to a drug treatment centre board.
Somers CJ; O'Connor J
Ir Med J; 2012 Oct; 105(9):295-8. PubMed ID: 23240280
[TBL] [Abstract][Full Text] [Related]
20. Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population.
Poling J; Oliveto A; Petry N; Sofuoglu M; Gonsai K; Gonzalez G; Martell B; Kosten TR
Arch Gen Psychiatry; 2006 Feb; 63(2):219-28. PubMed ID: 16461866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
